Auditable Variant Interpretation Platform Using Blockchain Evidence Models

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current variant interpretation support systems face challenges in reliably determining the phenotypic impact of molecular variants due to high numbers of variants of unknown significance, inconsistent and evolving knowledge, and the lack of uniform truth sets, leading to outdated and conflicting evidence models that complicate the evaluation and comparison of performance metrics.

Innovation Solution

A computer-implemented method that records evidence models, evaluates their performance, generates hash values for auditing, and ranks them based on validation and test performance data to provide the best-performing model for predicting phenotypic impacts, using machine learning techniques and a distributed data structure like blockchain for auditing and validation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If multiple evidence models are used to interpret molecular variants, then the coverage of variant interpretation is improved, but the complexity of evaluating and comparing performance metrics increases

Engineering Contradiction:
Improvecoverage of variant interpretationVSAvoidcomplexity of evaluating and comparing performance metrics
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies homogeneity by establishing a uniform evaluation framework that standardizes performance metrics across all evidence models. This allows for consistent comparison of diverse models using common criteria such as accuracy, precision, recall, and F1 score, thereby reducing the complexity of evaluating multiple models while maintaining comprehensive variant interpretation coverage

Inventive Principle:
Principle #33Homogeneity

Solution Approach 2:

The patent utilizes parameter changes by dynamically adjusting performance thresholds and weighting parameters based on variant characteristics and evidence model performance. This enables the system to optimize the combination of multiple evidence models for different variant types, improving interpretative coverage while managing evaluation complexity through adaptive parameter tuning

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If evidence models are updated continuously to reflect evolving knowledge, then the accuracy of phenotypic impact predictions is improved, but the stability of classification systems deteriorates

Engineering Contradiction:
Improveaccuracy of phenotypic impact predictionsVSAvoidstability of classification systems
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary action by implementing rigorous validation and testing protocols before updating evidence models with new knowledge. This ensures that only well-validated updates are incorporated, maintaining classification stability while progressively improving prediction accuracy through controlled knowledge integration

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent utilizes feedback mechanisms by continuously monitoring classification consistency and prediction accuracy across updates. When instability is detected, the system adjusts update frequencies or triggers re-validation, thereby maintaining stability while allowing continuous improvement of phenotypic impact predictions through controlled evolution of evidence models

Inventive Principle:
Principle #23Feedback

3Reliability

If comprehensive validation and testing of evidence models is performed, then the reliability of variant interpretation is improved, but the time required for model evaluation increases

Engineering Contradiction:
Improvereliability of variant interpretationVSAvoidtime required for model evaluation
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies partial action by implementing tiered validation strategies where critical evidence models undergo comprehensive validation while less critical models receive streamlined evaluation. This selective approach maintains high reliability for essential variant interpretations while reducing overall evaluation time through prioritized validation workflows

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The patent utilizes preliminary action by performing initial screening validations before full-scale testing. This preliminary filtering identifies models that require comprehensive validation versus those that can be quickly approved, thereby reducing total evaluation time while maintaining reliability through targeted thorough validation of critical models

Inventive Principle:
Principle #10Preliminary action

4Reliability

If audit trails are implemented for all evidence models, then the transparency and trustworthiness of variant interpretation is improved, but the complexity of data management increases

Engineering Contradiction:
Improvetransparency and trustworthinessVSAvoidcomplexity of data management
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies universality by implementing a standardized audit trail system that serves multiple functions simultaneously: tracking model versions, recording performance metrics, documenting validation results, and maintaining provenance information. This multi-functional audit infrastructure improves transparency and trustworthiness while avoiding the complexity of multiple separate tracking systems

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12136472B2Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
Publication Date: 2024.11.05 LABORATORY CORPORATION OF AMERICA HOLDINGS INC
  • US12136472B2 patent drawing
  • US12136472B2 patent drawing
  • US12136472B2 patent drawing

AI summary

Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.